Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women

Menopause

Volumn 16, Issue 5, 2009, Pages 1014-1020

  Kim, Hoon ^a   Chun, Sungwook ^a   Ku, Seung Yup ^a,b   Suh, Chang Suk ^a   Choi, Young Min ^a,b   Kim, Jung Gu ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Bone; Polymorphism; Tumor necrosis factor; Tumor necrosis factor receptor

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HEREDITY; HUMAN; KOREA; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE;

ABSORPTIOMETRY, PHOTON; AGED; ANALYSIS OF VARIANCE; BONE DENSITY; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, TUMOR NECROSIS FACTOR; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73349096918     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181a039c8     Document Type: Article

References (34)

1. NIH consensus statement. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795.
2. Jouanny P, Guillemin F, Kuntz C, Jaendel C, Pourel J. Environmental and genetic factors affecting bone mass: similarity of bone density among members of healthy families. Arthritis Rheum 1995;38:61-67.
3. Harris M, Nguyen TV, Howard GM, Kelly PJ, Eisman JA. Genetic and environmental correlations between bone formation and bone mineral density: a twin study. Bone 1998;22:141-145. (Pubitemid 28058504)
4. Kim JG, Lim KS, Kim EK, Choi YM, Lee JY. Association of vitamin. D receptor and estrogen, receptor gene polymorphisms with bone mass in postmenopausal Korean women. Menopause 2001;8:222-228. (Pubitemid 32410996)
5. Kim JG, Roh KR, Lee JY. The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism and bone mineral density in postmenopausal women in Korea. Am J Obstet Gynecol 2002;186:345-350. (Pubitemid 34234139)
6. Kim JG, Kwon JH, Kim SH, Choi YM, Moon SY, Lee JY. Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean women. Am J Obstet Gynecol 2003;189:1234-1240. (Pubitemid 37542151)
7. Kim JG, Lim KS, Ku SY, Kim SH, Choi YM, Moon SY. Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women. J Bone Miner Metab 2006;24:53-57. (Pubitemid 41821504)
8. Kim JG, Kim JH, Kim JY, et al. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 2007;14:913-918.
9. Weitzmann MN, Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev 2005;208:154-168.
10. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-l β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin. ligand gene expression, in human osteoblastic cells. Bone 1999;25:255-259. (Pubitemid 29406050)
11. Pacifici R. Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. Endocrinology 1998;139:2659-2661.
12. Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, Teitelbaum SL. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 2000;275:27307-27310. (Pubitemid 30688089)
13. Di Renzo GC, Coata G, Cosmi EV, Melis GB, Maietta L, Volpe A. Management of postmenopausal osteoporosis. Eur J Obstet Gynecol Reprod Biol 1994;56:47-53.
14. Ota N, Nakajima T, Ezura Y, et al. Association, of a single nucleotide variant in the human tumour necrosis factor α promoter region with decreased bone mineral density. Ann Hum Biol 2002;29:550-558. (Pubitemid 35235522)
15. Albagha OM, Tasker PN, McGuigan FE, Reid DM, Ralston SH. Linkage disequilibrium between polymorphisms in the human TNFRSFl B gene and their association with bone mass in perimenopausal women. Hum Mol Genet 2002;11:2289-2295.
16. Furuta I, Kobayashi N, Fujino T, et al. Bone mineral density of the lumbar spine is associated with. TNF gene polymorphisms in early postmenopausal Japanese women. Calcif Tissue Int 2004;74:509-515. (Pubitemid 38780286)
17. Chen HY, Chen WC, Hsu CM, Tsai FJ, Tsai CH. Tumor necrosis factor α, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol 2005;122:73-78.
18. Moffett SP, Zmuda JM, Oakley JI, et al. Tumor necrosis factor-α polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 2005;90:3491-3497.
19. Lee N, Fowler E, Mason S, Lincoln D, Taaffe DR, Radford-Smith G. Tumor necrosis factor-a haplotype is strongly associated with bone mineral density in patients with Crohn's disease J Gastroenterol Hepatol 2007;22:913-919. (Pubitemid 46911020)
20. Canhao H, Fonseca JE, Caetano-Lopes J, Saldanha C, Queiroz MV. Assessment of laboratory measurements and -308 TNF α gene promoter polymorphisms in normal bone mineral density. Clin Rheumatol 2008;27:301-307.
21. Spotila LD, Rodriguez H, Koch M, et al. Association of a polymorphism in the TNFR2 gene with low bone mineral density. J Bone Miner Res 2000;15:1376-1383. (Pubitemid 30413871)
22. Tasker PN, Albagha OM, Masson CB, Reid DM, Ralston SH. Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture. Osteoporos Int 2004;15:903-908. (Pubitemid 39506457)
23. Beutler BA. Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. Am J Med Sci 1992;303:129-133.
24. Sariban E, Imamura K, Luebbers R, Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 1988;81:1506-1510. (Pubitemid 18131619)
25. Stüber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within, the tumor necrosis factor locus influences plasma tumor necrosis factor-a concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-384. (Pubitemid 26097828)
26. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998;51:605-612. (Pubitemid 28306464)
27. Majetschak M, Flohé S, Obertacke U, et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999;230:207-214. (Pubitemid 30191887)
28. Skoog T, van't Hooft FM, Kallin B, et al. A common functional polymorphism (C - A substitution at position - 863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 1999;8:1443-1449. (Pubitemid 29374077)
29. Puga I, Lainez B, Fernández-Real JM, et al. A polymorphism, in the 3' untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression. Endocrinology 2005;146:2210-2220. (Pubitemid 40577508)
30. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
31. van Heel DA, Udalova IA, De Silva AP, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCTl and NF-κB transcription factors. Hum Mol Genet 2002;11:1281-1289.
32. Escobar-Morreale HF, Calvo RM, Sancho J, San Millán JL. TNF-α and hyperandrogenism: a clinical, biochemical, and molecular genetic study. J Clin Endocrinol Metab 2001;86:3761-3767. (Pubitemid 32755973)
33. Wennberg P, Nordström P, Lorentzon R, Lerner UH, Lorentzon M. TNF-α gene polymorphism and plasma TNF-α levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol 2002;146:629-634. (Pubitemid 34552495)
34. Payami H, Lee N, Zareparsi S, et al. Parkinson's disease, CY.P2D6 polymorphism, and age. Neurology 2001;56:1363-1370. (Pubitemid 32455299)